Clinical Trial Update: Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration [Phase 2]

View source ↗

Summary

This is a Phase 2 add-on trial evaluating metformin for brain remyelination and neurodegeneration in multiple sclerosis, including primary progressive and secon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Multiple Sclerosis, Primary Progressive Multiple Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING